Related Experiment Video

Updated: Jun 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Paediatric pneumococcal disease in Central Europe

R Prymula1, R Chlibek, I Ivaskeviciene

  • 1Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. prymula@fnhk.cz

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|June 14, 2011
PubMed

Insights

Pneumonia and meningitis caused by Streptococcus pneumoniae pose risks to children globally. This study found lower disease incidence in Central Europe but high fatality rates, highlighting the need for better surveillance to guide vaccination strategies.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Streptococcus pneumoniae causes significant global child illness and death.
  • Pneumococcal conjugate vaccines (PCVs) are available but their introduction requires accurate disease burden data.
  • Central Europe's pneumococcal disease burden requires updated epidemiological assessment.

Purpose of the Study:

  • To appraise the pneumococcal disease epidemiological situation in 11 Central European countries.
  • To evaluate the incidence and fatality rates of pneumococcal infections in the region.
  • To identify data gaps and recommend surveillance improvements for informed vaccination policy.

Main Methods:

  • Data synthesis from the 12th Central European Vaccine Advisory Group (CEVAG) meeting.
  • PubMed literature review using specific search terms for pneumococcal diseases and Central European countries.
  • Analysis of disease incidence and fatality rates, particularly in young children.

Main Results:

  • Pneumococcal disease incidence in Central Europe appears lower than previously reported for Europe overall.
  • The highest risk group for pneumococcal disease is infants aged 0-2 years.
  • Fatality rates from invasive pneumococcal infections in children under five can reach up to 40%.

Conclusions:

  • A lack of standardized surveillance hinders comprehensive country-specific data on pneumococcal disease burden.
  • Accurate evaluation of the pneumococcal disease burden in Central Europe necessitates standardized, active surveillance systems.
  • Improved surveillance is crucial for addressing the need for and optimizing the use of pneumococcal vaccination.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...